Clinical trial NCT00911209: Weight Loss in Pre-Hypertensive Patients With Diastolic Dysfunction
Official title: Impact of Weight Loss on Diastolic Dysfunction in Overweight Pre-Hypertensives
Study type: INTERVENTIONAL
Overall status: TERMINATED
Phase: NA
Conditions: Obesity
Heart Disease
Weight Loss
Diastolic Dysfunction
Keywords: Heart Disease
Obesity
Lead sponsor: Ohio State University
Sponsor class: OTHER
First posted: 2009-06-01
Enrollment: 1
Sex: ALL
Minimum age (years): 21
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The focus of this study is to observe the impact of weight loss in overweight individuals who have pre-hypertension (have a blood pressure reading of 121-139/81-89 mm Hg). The specific focus is to observe the difference in diastolic dysfunction (heart function) in these individuals at the beginning of the study and then again after 24-28 weeks. Diastolic dysfunction in this population indicates an increased risk of heart failure in the future. The aim of this study is to prevent or reduce the risk of heart failure in overweight individuals with pre-hypertension.

Detailed description: You will be enrolled in the study for 24-28 weeks and will be randomly assigned to one of two assigned group. One group of subjects (Intervention group) will receive information on Heart healthy diet, lifestyle recommendations and diet and exercise counseling with a dietitian in order to achieve at least 7% weight loss. The other group will receive standard of care i.e., Information on Heart healthy diet at baseline visit (Standard of care group). The following is the time line of activities anticipated by the subject in each group. Both the groups will be screened at 3 different visits within 4 weeks to determine eligibility. If you are eligible they will be randomized to either be in Standard of care group or Intervention group. After randomization, the "Standard of care group" will come for Baseline and Final visit (24th week). The Intervention group will have 14 weekly visits with a nutritionist and 1 monthly visit, about 40-50 minutes each visit (total of 15) in 24- 28 week time frame. The second monthly session will be the final assessment visit. Both the groups will have a Baseline Assessment and a Final Assessment visit which will last about 3 hours.

Eligibility criteria: Inclusion Criteria:

* Adults age ≥ 21 years
* BMI ≥30
* Individuals with diagnosis pre-hypertension at the time of screening, defined as either a blood pressure measurement of 130-139/85-89 mm Hg
* Echocardiographic EF \>50%
* Echocardiographic evidence of diastolic dysfunction;

Exclusion Criteria:

* Patients receiving antihypertensive medications
* Patients receiving diabetic medication

Primary outcomes:
measure: Determine if weight loss is associated with changes in separate components of cardiac function.
timeFrame: 32 weeks
Secondary outcomes:
measure: Determine whether specific cardiac markers will be altered in patients with diastolic dysfunction treated with low caloric diet and exercise and if these levels will be altered in association with improvement in diastolic function.
timeFrame: 24 weeks
Other outcomes:
Locations:
city: Columbus
country: United States
facility: The Ohio State University Medical Center
state: Ohio
Study officials:
affiliation: Ohio State University
name: Ragavendra Baliga, MD, MBA,
role: PRINCIPAL_INVESTIGATOR
References: